Wolverine Trading, LLC Adverum Biotechnologies, Inc. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 15, 2023	BUY	$1.5 - $2.33 $29,700 - $46,134	19,800 New	19,800 $29,000
Q4 2022 Feb 14, 2023	BUY	$0.54 - $10.3 $432 - $8,240	800 Added 5.88%	14,400 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $2,784 - $28,072	2,900 Added 27.1%	13,600 $13,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $2,187 - $3,618	-2,700 Reduced 20.15%	10,700 $13,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $22,509 - $35,685	-18,300 Reduced 57.73%	13,400 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $5,394 - $7,440	-3,100 Reduced 8.91%	31,700 $57,000
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $2,704 - $4,680	1,300 Added 3.88%	34,800 $77,000
Q2 2021 Aug 06, 2021	BUY	$3.36 - $10.56 $112,560 - $353,760	33,500 New	33,500 $118,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.